Scholar Rock (SRRK) and Omega Therapeutics (OMGA) were among decliners on Monday after Fibrogen's (FGEN) lung disorder drug pamrevlumab setback.
https://seekingalpha.com/news/3982855-scholar-rock-omega-stocks-lower-fibrogen-setback
Scholar Rock (SRRK) and Omega Therapeutics (OMGA) were among decliners on Monday after Fibrogen's (FGEN) lung disorder drug pamrevlumab setback.
https://seekingalpha.com/news/3982855-scholar-rock-omega-stocks-lower-fibrogen-setback
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.